These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9027285)

  • 1. [Outlook for using bacteria of the genus Bacillus for the design of new biopreparations].
    Sorokulova IB
    Antibiot Khimioter; 1996; 41(10):13-5. PubMed ID: 9027285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A comparative study of the biological properties of Biosporin and other commercial Bacillus-based preparations].
    Sorokulova IB
    Mikrobiol Z; 1997; 59(6):43-9. PubMed ID: 9511375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of antibiotic preparations and their combinations with probiotics on the intestinal microflora of mice].
    Furzikova TM; Sorokulova IB; Serhiĭchuk MH; Sichkar SV; Smirnov VV
    Mikrobiol Z; 2000; 62(3):26-35. PubMed ID: 10932540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A new preparation of biosporin and its effect on the intestinal microflora in dysbacterioses in newborn infants].
    Slabospitskaia AT; Vinogradov VP; Krymovskaia SS; Reznik SR; Smirnov VV
    Mikrobiol Z; 1995; 57(1):71-6. PubMed ID: 7728277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The highly effective biological preparation biosporin].
    Smyrnov VV; Reznyk SR; Sorokulova IV
    Lik Sprava; 1994; (5-6):133-8. PubMed ID: 7831880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The efficacy of the new bacterial preparation biosporin in treating acute intestinal infections].
    Gracheva NM; Gavrilov AF; Solov'eva AI; Smirnov VV; Sorokulova IB; Reznik SR; Chudnovskaia NV
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (1):75-7. PubMed ID: 8820685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The current concepts of the mechanisms of the therapeutic-prophylactic action of probiotics from bacteria in the genus Bacillus].
    Smirnov VV; Reznik SR; V'iunitskaia VA; Sorokulova IB; Samgorodskaia NV; Tofan AV
    Mikrobiol Z; 1993; 55(4):92-112. PubMed ID: 8220833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Susceptibility to antimicrobial drugs of strains of bacilli used as a basis for various probiotics].
    Smirnov VV; Rudenko AV; Samgorodskaia NV; Sorokulova IB; Reznik SR; Sergeĭchuk TM
    Antibiot Khimioter; 1994 Apr; 39(4):23-8. PubMed ID: 7826169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of the complex probiotic sporolact on the intestinal microbiocenosis of warm-blooded animals].
    Smirnov VV; Reznik SR; V'iunitskaia VA; Sorokulova IB; Litvin VP
    Mikrobiol Z; 1995; 57(4):42-9. PubMed ID: 8548069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of probiotics from bacilli on macrophage functional activity].
    Sorokulova IB
    Antibiot Khimioter; 1998; 43(2):20-3. PubMed ID: 9551169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigation of subalin effect on urogenital microflora of pregnant women].
    Sirokvasha EA; Paran'ko SI; Kozitskaia SN; Vinnikov AI
    Mikrobiol Z; 2002; 64(1):27-30. PubMed ID: 11944342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Safety of bacteria of the genus Bacillus, forming the base of some probiotics].
    Osipova IG; Sorokulova IB; Tereshkina NV; Grigor'eva LV
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (6):68-70. PubMed ID: 9949507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adequate therapy of intestinal dysbacteriosis in children].
    Bel'mer SV; Gasilina TV
    Klin Med (Mosk); 1998; 76(10):35-8. PubMed ID: 9865015
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pre-clinical trials of new spore probiotics].
    Osipova IG; Sorokulova IB; Vasil'eva EA; Budanova EV
    Vestn Ross Akad Med Nauk; 2005; (12):36-40. PubMed ID: 16404982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of sporulating bacteria in treating patients with dysbacteriosis].
    Voĭchishina LG; Chaplinskiĭ VIa; V'iunitskaia VA
    Vrach Delo; 1991 Dec; (12):73-5. PubMed ID: 1792782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The bacteriological and immunological efficacy of biosporin in nonspecific ulcerative colitis].
    Cherniakova VI; Bereza NM; Selezneva SI; Chaplinskiĭ VIa; Kudriavtseva VE; Mosalova NM; Shevtsova ZI; Tropko LV; Boĭko TI
    Mikrobiol Zh (1978); 1993; 55(3):63-7. PubMed ID: 8355632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of the cultivation conditions on the properties of bacilli comprising the basis of probiotics].
    Furzikova TM; Sergeĭchuk MG; Sorokulova IB; Smirnov VV
    Mikrobiol Z; 1999; 61(5):19-27. PubMed ID: 10643273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative evaluation of probiotic activity in respect to in vitro pneumotropic bacteria and pharmacodynamics of biosporin-strain producers in patients with chronic obstructive pulmonary diseases].
    Bilev AE
    Voen Med Zh; 2002 Sep; 323(9):54-7. PubMed ID: 12449758
    [No Abstract]   [Full Text] [Related]  

  • 19. [Bacillus subtilis metabolites as a novel promising probiotic preparations].
    Volkov MIu; Tkachenko EI; Vorobeĭchikov EV; Sinitsa AV
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (2):75-80. PubMed ID: 17523485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy of newborns with intestinal infections caused by opportunistic gram-negative aerobic bacteria].
    Litiaeva LA
    Antibiot Khimioter; 1991 Sep; 36(9):37-8. PubMed ID: 1781711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.